PREPARING FOR THE HAZARDS OF WAR
A Special Report from The Medical Letter

NEW ROCHELLE, NY -- March 26, 2003
     In light of recent global events and the threat of biological, chemical or nuclear terrorist attacks, The Medical Letter on Drugs and Therapeutics has published a collection of its recent articles on prevention and treatment of biological and chemical warfare attacks or nuclear accidents. The special issue, available to the public free of charge on The Medical Letter's Web site, www.medicalletter.org, contains five articles that were published during the past two years on the following topics:

•  Prevention and Treatment of Injury From Chemical Warfare Agents
•  Drugs and Vaccines Against Biological Weapons
•  Post-Exposure Anthrax Prophylaxis
•  Smallpox Vaccine
•  Potassium Iodide for Thyroid Protection in a Nuclear Accident or Attack.

     "With the potential threat of biological and chemical warfare, it is crucial to have access to unbiased information in order to make informed decisions about the available treatment options," said Gianna Zuccotti, Deputy Editor of The Medical Letter. "To help meet this need, The Medical Letter has decided, as a public service, to compile the articles in a single issue and make the information freely available."

     To view this collection of articles, please visit The Medical Letter's Public Reading Room at www.medicalletter.org/html/prm.htm.

About The Medical Letter
     The Medical Letter Inc., a nonprofit organization founded in 1958, offers health care professionals objective, independent analysis of new drugs. In addition to its biweekly newsletter, The Medical Letter on Drugs and Therapeutics, it also publishes handbooks and software on topics such as adverse drug interactions and antimicrobial therapy. The Medical Letter is supported entirely by subscriber fees and is based in New Rochelle, NY. For more information about The Medical Letter call (800) 211-2769 or visit their Web site at www.medicalletter.org.